Literature DB >> 21989848

Quantitative and molecular genetics of ADHD.

Philip Asherson1, Hugh Gurling.   

Abstract

ADHD is a common and highly heritable disorder. Family, twin, and adoption studies confirm a strong genetic influence in risk for ADHD and there has been a great deal of interest in identifying the genetic factors involved. Quantitative genetic studies find that genetic risk for ADHD is continuously distributed throughout the population, that there are both shared and unique genetic influences on inattention and hyperactivity-impulsivity, and that ADHD shares genetic risk factors with commonly co-occurring clinical syndromes and traits. ADHD is found at all ages and the underlying genetic architecture is similar across the lifespan. In terms of specific genetic findings, there is consistent evidence of monoamine neurotransmitter involvement with the best evidence coming from genetic markers in or near the dopamine D4 and D5 receptor genes. Recent genome-wide association studies have identified new association findings, including genes involved in cell division, cell adhesion, neuronal migration, and neuronal plasticity. However, as yet, none of these pass genome-wide levels of significance. Finally, recent data confirm an important role for rare copy number variants, including those that are found in schizophrenia and autism. Future work should use genetic association data to determine the nature of the cognitive, neuronal and cellular processes that mediate genetic risks on behaviour, and identify environmental factors that interact with genetic risks for ADHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21989848     DOI: 10.1007/7854_2011_155

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  11 in total

1.  Cross-generational transmission from drug abuse in parents to attention-deficit/hyperactivity disorder in children.

Authors:  K S Kendler; H Ohlsson; K Sundquist; J Sundquist
Journal:  Psychol Med       Date:  2016-04       Impact factor: 7.723

2.  Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study.

Authors:  J Sundquist; H Ohlsson; K Sundquist; K S Kendler
Journal:  Psychol Med       Date:  2014-08-14       Impact factor: 7.723

Review 3.  Teneurins and latrophilins: two giants meet at the synapse.

Authors:  Demet Araç; Jingxian Li
Journal:  Curr Opin Struct Biol       Date:  2019-04-02       Impact factor: 6.809

4.  Structural Basis of Latrophilin-FLRT-UNC5 Interaction in Cell Adhesion.

Authors:  Yue C Lu; Olha V Nazarko; Richard Sando; Gabriel S Salzman; Nan-Sheng Li; Thomas C Südhof; Demet Araç
Journal:  Structure       Date:  2015-07-30       Impact factor: 5.006

5.  Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.

Authors:  María Soler Artigas; Cristina Sánchez-Mora; Paula Rovira; Vanesa Richarte; Iris Garcia-Martínez; Mireia Pagerols; Ditte Demontis; Sven Stringer; Jacqueline M Vink; Anders D Børglum; Benjamin M Neale; Barbara Franke; Stephen V Faraone; Miguel Casas; Josep Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Mol Psychiatry       Date:  2019-01-04       Impact factor: 13.437

6.  Polymorphism in variable number of tandem repeats of dopamine d4 gene is a genetic risk factor in attention deficit hyperactive egyptian children: pilot study.

Authors:  Ola Shahin; Nagwa A Meguid; Omnia Raafat; Reham M Dawood; Malak Doss; Noha G Bader El Din; Mostafa K El Awady
Journal:  Biomark Insights       Date:  2015-05-05

7.  ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats.

Authors:  Anna Kozłowska; Paweł Wojtacha; Maciej Równiak; Małgorzata Kolenkiewicz; Andrew Chih Wei Huang
Journal:  Psychopharmacology (Berl)       Date:  2019-02-08       Impact factor: 4.530

Review 8.  Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Authors:  Silvia Pasquini; Chiara Contri; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

9.  Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

Authors:  Mireia Pagerols; Vanesa Richarte; Cristina Sánchez-Mora; Paula Rovira; María Soler Artigas; Iris Garcia-Martínez; Eva Calvo-Sánchez; Montse Corrales; Bruna Santos da Silva; Nina Roth Mota; Marcelo Moraes Victor; Luis Augusto Rohde; Eugenio Horacio Grevet; Claiton Henrique Dotto Bau; Bru Cormand; Miguel Casas; Josep Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

10.  Attention-deficit/hyperactivity disorder symptoms and dietary habits in adulthood: A large population-based twin study in Sweden.

Authors:  Lin Li; Mark J Taylor; Katarina Bälter; Ralf Kuja-Halkola; Qi Chen; Tor-Arne Hegvik; Ashley E Tate; Zheng Chang; Alejandro Arias-Vásquez; Catharina A Hartman; Henrik Larsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-10-07       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.